Phibro Animal Health Corporation
US ˙ NasdaqGM ˙ US71742Q1067

SecurityPAHC / Phibro Animal Health Corporation
InstitutionQube Research & Technologies Ltd
Latest Disclosed Ownership208,449 shares
Latest Disclosed Value $ 11,529,314
Qube Research & Technologies Ltd reports 28.56% decrease in ownership of PAHC / Phibro Animal Health Corporation

On May 15, 2026 - Qube Research & Technologies Ltd filed a 13F-HR form disclosing ownership of 208,449 shares of Phibro Animal Health Corporation (US:PAHC) valued at $11,529,314 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 291,773 shares of Phibro Animal Health Corporation. This represents a change in shares of -28.56% during the quarter. The current value of the position is $6,626,594 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 208,449 -83,324 -28.56 11,529 5.77 0.0128
2026-02-17 2025-12-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 291,773 36,420 14.26 10,901 5.51 0.0111
2025-11-14 2025-09-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 255,353 73,231 40.21 10,332 122.12 0.0107
2025-08-14 2025-06-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 182,122 33,548 22.58 4,651 46.58 0.0047
2025-05-15 2025-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 148,574 94,251 173.50 3,174 178.33 0.0037
2025-02-14 2024-12-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 54,323 54,323 1,141 0.0015
2024-05-14 2024-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 0 -8,904 -100.00 0 -100.00
2024-02-13 2023-12-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 8,904 6,231 233.11 103 202.94 0.0002
2023-11-13 2023-09-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 2,673 2,673 34 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.